Search Login Register
Clarithromycin
(Biaxin)
Summary
Description:
A semisynthetic macrolide antibiotic derived from ERYTHROMYCIN that is active against a variety of microorganisms. It can inhibit protein synthesis in bacteria by reversibly binding to the 50S ribosomal subunits. This inhibits the translocation of aminoacyl transfer-RNA and prevents peptide chain elongation.
Also Known As:
Biaxin; 6-O-Methylerythromycin; A-56268; TE-031; A 56268 Show All >>
Networked: 2335
relevant articles (386 outcomes,
358 trials/studies)
for this Drug
Key Diseases for which Clarithromycin is
Relevant
-
Infection
:
139 outcomes 87 studies in 873 results
-
Pneumonia (Pneumonitis)
:
38 outcomes 36 studies in 163 results
-
Duodenal Ulcer (Curling's Ulcer)
:
21 outcomes 16 studies in 121 results
-
Chronic Bronchitis
:
14 outcomes 24 studies in 61 results
-
Acquired Immunodeficiency Syndrome (AIDS)
:
14 outcomes 19 studies in 96 results
Show All >>
Drugs Related to Clarithromycin
-
Amoxicillin (Wymox)
-
Azithromycin (Zithromax)
-
Omeprazole (Esomeprazole)
-
Erythromycin (Erycette)
-
Metronidazole (Metric)
-
Ciprofloxacin (Cipro)
-
Ethambutol (Myambutol)
-
Rifampin (Rifampicin)
-
Rifabutin (Ansamycin)
-
Anti-Bacterial Agents (Antibiotics)
Show All >>
Therapies Related to Clarithromycin
-
Drug Therapy (Chemotherapy)
-
Aftercare (After-Treatment)
-
Debridement
-
Oral Administration
-
Stents
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.